中文版
Home>NEWS>ANSO News

ANSO Representative Attend the International Summit for Innovation and Development of Biomedicine Industry

Xinhua

12 09, 2019

 

The International Summit for Innovation and Development of Biomedicine Industry was held in Shenzhen on September 11-12, 2019. More than 500 participants with a number of well-known scientists, medical doctors, experts, medical companies and venture capital fund representatives from the US, France, China, Hong Kong and other parts of the world joined together to discuss the development of the research, innovation and technology on biomedicine in Guangdong-Hong Kong-Macao Greater Bay Area (GBA), and to make GBA a world center of biomedicine industry.

 

 

 

 

Prof. Cao, the Executive Director of the ANSO Secretariat and Head of the Preparatory Committee of CAS-Hong Kong Innovation Research Center, attended the panel discussion titled “How Does Innovation Drive the Development of Biomedicine Industry in GBA region?” . Cao pointed out that the active S&T innovation and resource sharing are the key driving forces for the development of GBA. Hong Kong is a highly international metropolis with advanced scientific research and medical system. The motivation of CAS-Hong Kong Innovation Center is to build an integrated platform for utilizing and optimizing resources from both Hong Kong and the mainland China. Cao also introduced the effort of ANSO on innovation and technology transfer in the field of traditional and new medicine.

 

 

 

 

 

CONTACTS ANSO SECRETARIAT

Tel: 86-10-84097121 Email: anso-public@anso.org.cn Location: No.16 Lincui Road, Chaoyang District, Beiing, China